GlassScriptPhysician profile
Darin R Serletic
NPI 1528040714
$1,675.64
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $18.03 · 2021: $119 · 2022: $48.46 · 2023: $1,041 · 2024: $137 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $700 · Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $700.11 |
| Food and Beverage | $629.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $993.31 | 2023 | |
| Organogenesis INC. | $371.49 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Kerecis Limited | $70.22 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $47.77 | 2019 | |
| Smith+Nephew, INC. | $35.11 | 2024 | Renasys Touch, Collagenase Santyl, Regranex |
| Orthofix Medical, INC. | $28.85 | 2025 | Physio-Stim |
| Next Science LLC | $26.93 | 2023 | Blastx, Xperience, Surgx |
| Polynovo North America LLC | $21.97 | 2024 | Novosorb Btm |
| Nevro Corp. | $18.99 | 2024 | Senza |
| Reprise Biomedical, INC. | $18.63 | 2025 | Miro 3d |
| Bioventus LLC | $14.45 | 2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $14.20 | 2025 | Nuzyra |
| Kci USA, INC. | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Serletic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.